factually
Index/Topics/CGM Access Inequity 2026

CGM Access Inequity 2026

The inequitable access to Continuous Glucose Monitors (CGMs) and modern pharmacotherapies in underserved populations due to various barriers.

Fact-Checks

1 result
Jan 17, 2026
Most Viewed

What barriers (cost, access, training) limit use of CGM and newer diabetes medications in underserved populations?

Continuous glucose monitors (CGMs) and newer glucose-lowering agents such as GLP‑1 receptor agonists and SGLT2 inhibitors promise better outcomes, but their uptake in underserved populations is constr...